SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Conformis, Inc. CFMS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Conformis, Inc. (CFMS) is a Medical - Devices company in the Healthcare sector, currently trading at $2.27. It has a SharesGrow Score of 19/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $62M, -1.3%/yr average growth. Net income is $50M (loss), growing at -629%/yr. Net profit margin is -81.3% (negative). Gross margin is 37.4% (-10 pp trend).

Balance sheet: total debt is $27M against $54M equity (Debt-to-Equity (D/E) ratio 0.51, moderate). Current ratio is 5.63 (strong liquidity). Debt-to-assets is 29.2%. Total assets: $94M.

Analyst outlook: 2 / 6 analysts rate CFMS as buy (33%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 50/100 (Partial), Moat 21/100 (Fail), Future 20/100 (Fail), Income 10/100 (Fail).

CFMS SharesGrow Score Overview

23/100

SharesGrow Score

Below average — proceed with caution

View full scorecard →

VALUE 0/100

Valuation — P/E, PEG, Forward PEG

GROWTH 15/100

Financials — average growth

PAST 0/100

strong — trend

HEALTH 50/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 21/100

Gross margin is + market cap

FUTURE 20/100

Analyst outlook — as buy

INCOME 10/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CFMS

No analyst coverage available for this stock.

CFMS: -1.3%/yr revenue is, -629%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

No analyst coverage available for this stock.

Balance sheet CFMS: Debt-to-Equity (D/E) ratio 0.51 (moderate), Current ratio is 5.63 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

CFMS: Gross margin is 37.4% (-10 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 21/100. ≥ 70 = Pass.

View details →

Analyst outlook: 2 / 6 analysts rate CFMS as buy (33%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

CFMS: Net profit margin is -81.3%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range1.05-7.25

Volume7.08K

Avg Volume (30D)156.85K

Market Cap$17.88M

Beta (1Y)1.42

Share Statistics

EPS (TTM)-6.99

Shares Outstanding$7.22M

IPO Date2015-07-01

Employees295

CEOMark A. Augusti

Financial Highlights & Ratios

Revenue (TTM)$62.05M

Gross Profit$23.21M

EBITDA$-46.23M

Net Income$-50.47M

Operating Income$-46.28M

Total Cash$48.67M

Total Debt$27.5M

Net Debt$-21.17M

Total Assets$94.05M

Price / Earnings (P/E)-0.3

Price / Sales (P/S)0.29

Analyst Forecast

Rating ConsensusHold

Analysts Covering6

Buy 33% Hold 50% Sell 17%

Company Info

CountryUS

ExchangeNASDAQ Capital Marke

CurrencyUSD

ISINUS20717E1010

Price Chart

CFMS

Conformis, Inc. ↗ · NASDAQ Capital Marke

Healthcare • Medical - Devices

1.05 52WK RANGE 7.25

People Also View

Avanos Medical, Inc.

NeuroPace, Inc.

Orthofix Medical Inc.

OrthoPediatrics Corp.

Anika Therapeutics, Inc.

Sight Sciences, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message